Company
Vilya
| Industry | biotechnology company creating a new class of medicines that precisely target disease biology, expanded its Series A funding to $71M |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Vilya | Series A Financing | 2024-06-05 |
| Vilya | Series A | 2022-08-29 |